Stat | Pharmalot Vertex also faces a drug-price fight in Canada

Stat | Pharmalot Vertex also faces a drug-price fight in Canada


Yet another country has begun battling with Vertex Pharmaceuticals over its cystic fibrosis medicines. In a new report, an independent Canadian advisory group has rejected the use of the company's Orkambi treatment over questions about both its cost and clinical effectiveness.



from Biotech News